Mounjaro® Rx in Aventura, FL

In May 2022, the FDA approved this prescription medication, tirzepatide, under the brand name Mounjaro, for the treatment of diabetes type 2. It is a once-weekly injection designed for adults to help keep their blood sugar in balance. During clinical trials, this medication was found to promote significant weight loss when it was used together with healthy lifestyle choices.

This medication prescription was used “off-label” while the manufacturer, Eli Lilly and Company, was waiting to get Mounjaro approved for weight loss by the FDA.

Approval was granted in November 2023 under the brand name Zepbound for the treatment of obesity in adults over the age of 18. The medication in both injections is exactly the same; however, the dosage used is lower for the treatment of diabetes than when used for weight loss.

Mounjaro prescription injections are usually self-administered into a fatty area of your outer thigh, outside upper arm, or abdominal area, and these sites should be rotated to prevent one from becoming overly irritated or tender. You should administer your injection on the same day of the week and as close to the same time as possible. There is no “best time of day to take Mounjaro, and you should choose the day and time that work best for your schedule so you will take it consistently.

When you pick up your mounjaro prescription, you will be given four prefilled single-use injection pens, each containing the exact dose you need to take each week during that month. Your doctor will provide you with detailed instructions on how to administer your injections, but the basic steps are as follows:

Keep the pens refrigerated until you are ready to do your injection. When you remove one for use, do not remove the grey base cap until you are about to administer your injection.

Many individuals experience nausea and vomiting when starting tirzepatide and other types of GLP-1 medications. To help prevent severe symptoms, patients begin their injections with a very low dose and gradually work up to the highest dose. The dose is increased approximately every four weeks over the course of six months.

If you are already using another GLP-1 medication, have had medullary thyroid carcinoma, gallbladder issues, kidney or pancreas problems, or have been diagnosed with MEN type-2, Mounjaro may not be right for you. You should not use this medication if you are allergic to any of the ingredients that are contained within or if you are pregnant, nursing, or are planning to get pregnant soon.

Mounjaro is meant for adults who are at least 18 years old, and have type-2 diabetes, or are overweight or obese. These individuals have tried on their own to lose weight, but traditional methods have been unsuccessful for them. Their body mass index is at least 30 or 27, and they have health problems that are related to their weight, such as high blood pressure, sleep apnea, etc.

Since this is the only weight loss medication that emulates two of the body’s naturally occurring hormones, Mounjaro has shown the most significant weight loss results compared to Semaglutide-based injections. Patients suffering from type 2 diabetes lost an average of 16% of their total body weight in 18 months, and non-diabetic individuals showed weight loss results of approximately 21% of their total body weight.